跳到正文
原文
The Lancet· Reena H Doshi, Irene Lubega, Pierre Muhoza, Grace Carlock, Arthur Brian Sekiziyivu, Alexandra Tuttle, Marjorie Najjengo, John Kayiwa, Rebecca Casey, Eric C Mossel, Winfred Nakato, Conrad Tumwine, Ellon Twinomuhwezi, Julius Lutwama, Annet Nankya, Leonara Rebecca Nabatanzi, Semakula Charles, Allison M Brown, Jennifer Harris, Leora Feldstein, Susan Chu, Hongjiang Gao, Andrew Kambugu, J Erin Staples, Terri B Hyde·· 2026-09-12精选AI 评分58

乌干达9–23月龄儿童试验:17DD黄热病疫苗五分之一与半剂量免疫原性不劣于全剂量

[Articles] Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9–23 months in Uganda: a phase 4, single-blind, randomised clinical trial

AI 导读

一项在乌干达9–23月龄儿童中开展的4期单盲随机临床试验显示,17DD黄热病疫苗的五分之一剂量和半剂量在诱导初始血清阳转方面均不劣于全剂量。研究结果支持在疫苗供应短缺期间将分剂量黄热病疫苗用于幼儿的暴发应对。

推荐理由

乌干达幼儿的4期随机试验显示,17DD黄热病疫苗五分之一和半剂量的免疫原性不劣于全剂量,为供应短缺时的暴发应对提供依据。

来源:The Lancet · thelancet.com